Pricing

Vedere Bio

0 followers

‌

Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links

Org chart

Daniel Zimmer

Senior Director, Program Lead

Ellen Zyrkowski

Associate Director, HR & Communications

Soraya Bekkali, MD

Non Executive Director

Xiaozhi Ren (任小峙) Ph.D.

Director, CMC, Cell Line and Process Development

Karen Guerin

Senior Director, Discovery Research

Teams

Leadership Team

2 members

Research and Development

4 members

Similar companies

Capricor Therapeutics

1 follower

Elicio Therapeutics

1 follower

Housed

4 followers

Artiva Biotherapeutics

1 follower

Authentic Restaurant Brands

4 followers

Thermo Fisher Scientific

160 followers

Regeneron

92 followers

ByHeart

2 followers

Roivant Sciences

56 followers

Natera

13 followers

10X Genomics

13 followers

Explore companies